Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients

E. Villa, P. Buttafoco, A. Merighi, A. Grottola, I. Ferretti, A. Ferrari, F. Callea, P. Trande, A. M. Rebecchi, F. Manenti

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The behavior of hepatitis C virus (HCV) infection with regards to type and number of HCV genotypes (tested with genotype-specific nested polymerase chain reaction) was evaluated in 60 patients with anti-HCV-positive chronic active hepatitis without cirrhosis [17 untreated and 43 subjects undergoing single or repeat courses of interferon (IFN) therapy] during a mean follow-up period of 76±18 months. In untreated patients (2 genotype I, 6 genotype II, 9 mixed infections) 4 out of 9 mixed infections selected for genotype II at the end of follow-up. Of the 43 treated patients 10 were long-term responders with histological remission, 6 were shortterm responders, and 22 did not respond. Fifteen of the latter patients received another course of IFN therapy, and only 3 patients responded. Eight of the 10 responders had infection with a single genotype (4 gt I, 3 gt II, 3 gt III). After IFN therapy, all but 2 patients cleared the HCV infection. The responders to the second IFN course (1 gt I, 1 gt II, 1 gt III) remained viremic. Of the shortterm responders, 2/6 patients had genotype II and 4 had a mixed infection (3 gt II±I and 1 gt II±III); gt III became prevalent in the latter in all but one patient. Of the nonresponders 18/24 had more than one genoytpe, 5 were genotype II at baseline and one had genotype I. At the end of the follow-up period 15/18 with mixed infection had selected for gt II (P

Original languageEnglish
Pages (from-to)249-254
Number of pages6
JournalJournal of Molecular Medicine
Volume73
Issue number5
DOIs
Publication statusPublished - May 1995

Fingerprint

Hepacivirus
Interferons
Genotype
Coinfection
Virus Diseases
Chronic Hepatitis
Fibrosis
Therapeutics
Polymerase Chain Reaction
Infection

Keywords

  • Chronic active hepatitis
  • Genotypes
  • Hepatitis C virus
  • Interferon

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Villa, E., Buttafoco, P., Merighi, A., Grottola, A., Ferretti, I., Ferrari, A., ... Manenti, F. (1995). Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. Journal of Molecular Medicine, 73(5), 249-254. https://doi.org/10.1007/BF00189925

Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. / Villa, E.; Buttafoco, P.; Merighi, A.; Grottola, A.; Ferretti, I.; Ferrari, A.; Callea, F.; Trande, P.; Rebecchi, A. M.; Manenti, F.

In: Journal of Molecular Medicine, Vol. 73, No. 5, 05.1995, p. 249-254.

Research output: Contribution to journalArticle

Villa, E, Buttafoco, P, Merighi, A, Grottola, A, Ferretti, I, Ferrari, A, Callea, F, Trande, P, Rebecchi, AM & Manenti, F 1995, 'Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients', Journal of Molecular Medicine, vol. 73, no. 5, pp. 249-254. https://doi.org/10.1007/BF00189925
Villa, E. ; Buttafoco, P. ; Merighi, A. ; Grottola, A. ; Ferretti, I. ; Ferrari, A. ; Callea, F. ; Trande, P. ; Rebecchi, A. M. ; Manenti, F. / Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. In: Journal of Molecular Medicine. 1995 ; Vol. 73, No. 5. pp. 249-254.
@article{04ad50ee915a4d8b81ce76861e1ac889,
title = "Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients",
abstract = "The behavior of hepatitis C virus (HCV) infection with regards to type and number of HCV genotypes (tested with genotype-specific nested polymerase chain reaction) was evaluated in 60 patients with anti-HCV-positive chronic active hepatitis without cirrhosis [17 untreated and 43 subjects undergoing single or repeat courses of interferon (IFN) therapy] during a mean follow-up period of 76±18 months. In untreated patients (2 genotype I, 6 genotype II, 9 mixed infections) 4 out of 9 mixed infections selected for genotype II at the end of follow-up. Of the 43 treated patients 10 were long-term responders with histological remission, 6 were shortterm responders, and 22 did not respond. Fifteen of the latter patients received another course of IFN therapy, and only 3 patients responded. Eight of the 10 responders had infection with a single genotype (4 gt I, 3 gt II, 3 gt III). After IFN therapy, all but 2 patients cleared the HCV infection. The responders to the second IFN course (1 gt I, 1 gt II, 1 gt III) remained viremic. Of the shortterm responders, 2/6 patients had genotype II and 4 had a mixed infection (3 gt II±I and 1 gt II±III); gt III became prevalent in the latter in all but one patient. Of the nonresponders 18/24 had more than one genoytpe, 5 were genotype II at baseline and one had genotype I. At the end of the follow-up period 15/18 with mixed infection had selected for gt II (P",
keywords = "Chronic active hepatitis, Genotypes, Hepatitis C virus, Interferon",
author = "E. Villa and P. Buttafoco and A. Merighi and A. Grottola and I. Ferretti and A. Ferrari and F. Callea and P. Trande and Rebecchi, {A. M.} and F. Manenti",
year = "1995",
month = "5",
doi = "10.1007/BF00189925",
language = "English",
volume = "73",
pages = "249--254",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients

AU - Villa, E.

AU - Buttafoco, P.

AU - Merighi, A.

AU - Grottola, A.

AU - Ferretti, I.

AU - Ferrari, A.

AU - Callea, F.

AU - Trande, P.

AU - Rebecchi, A. M.

AU - Manenti, F.

PY - 1995/5

Y1 - 1995/5

N2 - The behavior of hepatitis C virus (HCV) infection with regards to type and number of HCV genotypes (tested with genotype-specific nested polymerase chain reaction) was evaluated in 60 patients with anti-HCV-positive chronic active hepatitis without cirrhosis [17 untreated and 43 subjects undergoing single or repeat courses of interferon (IFN) therapy] during a mean follow-up period of 76±18 months. In untreated patients (2 genotype I, 6 genotype II, 9 mixed infections) 4 out of 9 mixed infections selected for genotype II at the end of follow-up. Of the 43 treated patients 10 were long-term responders with histological remission, 6 were shortterm responders, and 22 did not respond. Fifteen of the latter patients received another course of IFN therapy, and only 3 patients responded. Eight of the 10 responders had infection with a single genotype (4 gt I, 3 gt II, 3 gt III). After IFN therapy, all but 2 patients cleared the HCV infection. The responders to the second IFN course (1 gt I, 1 gt II, 1 gt III) remained viremic. Of the shortterm responders, 2/6 patients had genotype II and 4 had a mixed infection (3 gt II±I and 1 gt II±III); gt III became prevalent in the latter in all but one patient. Of the nonresponders 18/24 had more than one genoytpe, 5 were genotype II at baseline and one had genotype I. At the end of the follow-up period 15/18 with mixed infection had selected for gt II (P

AB - The behavior of hepatitis C virus (HCV) infection with regards to type and number of HCV genotypes (tested with genotype-specific nested polymerase chain reaction) was evaluated in 60 patients with anti-HCV-positive chronic active hepatitis without cirrhosis [17 untreated and 43 subjects undergoing single or repeat courses of interferon (IFN) therapy] during a mean follow-up period of 76±18 months. In untreated patients (2 genotype I, 6 genotype II, 9 mixed infections) 4 out of 9 mixed infections selected for genotype II at the end of follow-up. Of the 43 treated patients 10 were long-term responders with histological remission, 6 were shortterm responders, and 22 did not respond. Fifteen of the latter patients received another course of IFN therapy, and only 3 patients responded. Eight of the 10 responders had infection with a single genotype (4 gt I, 3 gt II, 3 gt III). After IFN therapy, all but 2 patients cleared the HCV infection. The responders to the second IFN course (1 gt I, 1 gt II, 1 gt III) remained viremic. Of the shortterm responders, 2/6 patients had genotype II and 4 had a mixed infection (3 gt II±I and 1 gt II±III); gt III became prevalent in the latter in all but one patient. Of the nonresponders 18/24 had more than one genoytpe, 5 were genotype II at baseline and one had genotype I. At the end of the follow-up period 15/18 with mixed infection had selected for gt II (P

KW - Chronic active hepatitis

KW - Genotypes

KW - Hepatitis C virus

KW - Interferon

UR - http://www.scopus.com/inward/record.url?scp=0029032775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029032775&partnerID=8YFLogxK

U2 - 10.1007/BF00189925

DO - 10.1007/BF00189925

M3 - Article

VL - 73

SP - 249

EP - 254

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 5

ER -